At a glance
ClinicalIndex Comparison RecordN/ACompleted· 751,725 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
In Brief
An observational study for Schizophrenia and Bipolar Disorder. Completed, enrolled 751,725 participants across 16 sites.
Detailed Summary
Multicentre, retrospective observational cohort study based on LHU administrative databases aimed to described the pharmacoutilization of antipsychotics in patients affected by schizophrenia and bipolar disorder, the resource consumption and medication adherence. A sub analysis will be performed for those patients switching from Quetiapine IR to Quetiapine XR and comparing the periods before and after the switch.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Bipolar Disorder
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedJul 2011
Primary CompletionSep 2012
TodayJul 2026
First PostedJul 12, 2011
Enrollment StartJul 1, 2011
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.0 years ago